Lakewood-Amedex Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lakewood-Amedex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11273
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lakewood-Amedex Inc (Lakewood-Amedex) is a clinical-stage pharmaceutical company with focus on the development of antimicrobial and antifungal medicines to address unmet needs in the treatment of serious infectious diseases. The company develops anti-infective products such as anti-bacterial compounds, gene-silencing antivirals, locally delivered and orally available nanoRNA therapeutics. Its antimicrobial product pipeline includes Nu-3, small protonated nucleotide derivative molecules used for the treatment of complicated diabetic foot ulcers (cDFU); Nu-8, is intended to treat complicated urinary tract infections (cUTI) and Cystic Fibrosis. The company works in partnership with other biopharmaceutical companies, animal health companies, and academic and government institutions. Lakewood-Amedex is headquartered in Sarasota, Florida, the US.

Lakewood-Amedex Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Lakewood-Amedex Raises USD1 Million in Venture Financing 10
Lakewood-Amedex Raises USD5.5 Million in Series C Financing 11
Partnerships 12
Lakewood-Amedex Expands Research Agreement with University of Jyvaskyla 12
Lakewood-Amedex Enters into Co-Development Agreement with Ethicor Pharma 13
Lakewood-Amedex Inc – Key Competitors 14
Lakewood-Amedex Inc – Key Employees 15
Lakewood-Amedex Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
May 11, 2018: Lakewood-Amedex Elects Stephen Evans-Freke as New Chairman of the Board of Directors 17
Product News 18
11/28/2017: Lakewood-Amedex to Present at the 10th Annual LD Micro Main Event 18
09/27/2017: Lakewood-Amedex Reports Positive Top-Line Data from Randomized Controlled Phase 1/2a Trial of Nu-3 Antimicrobial in Patients with Infected Diabetic Foot Ulcers 19
08/31/2017: Lakewood-Amedex Strengthens Board of Directors with Two Industry Veterans 20
08/22/2017: Lakewood-Amedex Completes Clinical Trial Recruitment for Final Cohort of the Companys Phase 1/2a Program in Patients with Infected Diabetic Foot Ulcers 21
02/08/2018: Lakewood-Amedex to Present Clinical Update on Nu-3 at 2018 BIO CEO & Investor Conference 22
02/08/2018: Lakewood-Amedex to Present Pre-Clinical Update on Nu-8 at 2018 BIO CEO & Investor Conference 23
Clinical Trials 24
Dec 04, 2017: Lakewood-Amedex Advances Bisphosphocin Nu-8 to IND-Enabling Studies to Treat Complicated Urinary Tract Infection 24
Apr 04, 2017: Lakewood-Amedex Advances Novel Bisphosphocin Nu-8 Compound Based on Encouraging Pre-Clinical Results 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Key Facts 2
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lakewood-Amedex Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lakewood-Amedex Raises USD1 Million in Venture Financing 10
Lakewood-Amedex Raises USD5.5 Million in Series C Financing 11
Lakewood-Amedex Expands Research Agreement with University of Jyvaskyla 12
Lakewood-Amedex Enters into Co-Development Agreement with Ethicor Pharma 13
Lakewood-Amedex Inc, Key Competitors 14
Lakewood-Amedex Inc, Key Employees 15

List of Figures
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lakewood-Amedex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Lakewood-Amedex Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cellerant Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cellerant Therapeutics Inc (Cellerant) develops novel immunotherapies for oncology and blood-related disorders. Its lead product, CLT-008, is a myeloid progenitor cell therapy which is in Phase 2 clinical development in patients with acute myeloid leukemia (AML). Cellerant develops various c …
  • Connect Group PLC (CNCT):企業の財務・戦略的SWOT分析
    Connect Group PLC (CNCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Petroleo Brasileiro SA (PETR4):企業の財務・戦略的SWOT分析
    Petroleo Brasileiro SA (PETR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • JSW Steel Ltd:企業の戦略・SWOT・財務情報
    JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report Summary JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Duraloy Technologies Inc:企業の戦略的SWOT分析
    Duraloy Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Dhofar Tourism Company SAOG:企業の戦略・SWOT・財務情報
    Dhofar Tourism Company SAOG - Strategy, SWOT and Corporate Finance Report Summary Dhofar Tourism Company SAOG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Orsted Salg & Service AS:企業の戦略的SWOT分析
    Orsted Salg & Service AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • SoftwareONE Holding AG (SWON):企業の財務・戦略的SWOT分析
    SoftwareONE Holding AG (SWON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Alnylam Pharmaceuticals Inc (ALNY):企業の財務・戦略的SWOT分析
    Alnylam Pharmaceuticals Inc (ALNY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cpp Group Plc (CPP):企業の財務・戦略的SWOT分析
    Summary Cpp Group Plc (CPP), is a provider of bespoke products and solutions. It offers flight disruption insurance, legal protection, autocare, assetcare and mobile phone insurance. It offers services such as airport angel, card rescue, card protection, packaged accounts and travel assistance. CPP …
  • Oasis Petroleum Inc (OASPQ):企業の財務・戦略的SWOT分析
    Oasis Petroleum Inc (OASPQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Ardent Health Services:企業の戦略・SWOT・財務分析
    Ardent Health Services - Strategy, SWOT and Corporate Finance Report Summary Ardent Health Services - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • First Republic Bank:企業のM&A・事業提携・投資動向
    First Republic Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First Republic Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Toma Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Toma Biosciences Inc (Toma Biosciences) is a biotechnology company that provides genome sequencing solutions. The company launched TOMA OS-Seq cancer assay to laboratories and researchers for the changes in tumors. Its products include reagent kits developed to detect genomic changes in canc …
  • Trinity Industries, Inc (TRN):電力:M&Aディール及び事業提携情報
    Summary Trinity Industries, Inc. (Trinity) is a diversified industrial company. It produces and supplies railcars and railcar parts, inland barges, aggregates and highway products. It also manufactures tank containers, steel parts and structural wind towers. It also offers services such as railcar f …
  • Thornton & Ross Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Thornton & Ross Ltd (Thornton & Ross), a subsidiary of Stada Arzneimittel AG is a supplier of medicines and healthcare products. The company offers over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and semi-solids. Thornton & Ross’ products compris …
  • ORChem Co., Ltd.:企業のM&A・事業提携・投資動向
    ORChem Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ORChem Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Fujita Kanko Inc:企業の戦略・SWOT・財務情報
    Fujita Kanko Inc - Strategy, SWOT and Corporate Finance Report Summary Fujita Kanko Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kuala Lumpur Kepong Berhad (KLK):企業の財務・戦略的SWOT分析
    Kuala Lumpur Kepong Berhad (KLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆